Kiromic: The Intersection of Big Data Science and Immuno-Oncology

Dec. 3, 2020
Kiromic BioPharma (NASDAQ: KRBP) is a target discovery and gene-editing company utilizing artificial intelligence and its proprietary neural network platform with a therapeutic focus on immuno-oncology. Visit KRBPinfo.com to learn more.

 Read More

Bloomberg TV Show

CEO Interviews

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market